Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]
The complaint alleges that the injury was the result of the use of Ozempic and Wegovy
In rodent models, activation of the GLP-1 neurons also results in activation of stress responses, including anxiety-like behavior (Maniscalco and Rinaman, 2018)
LIPO-B is often used alongside GLP-1 therapy or a structured weight-management program to support energy and fat utilization during caloric deficit
Whether you seek improved immune support, enhanced cognitive function, or better overall well-being, Confident Health simplifies the path to better health